At a Glance
| Desoxypipradrol | 2-FMA | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (insufflated) | 1.5–3.5 mg | 15–30 mg |
| Total Duration | 8.3–40 hrs | 1.5–4 hrs |
| Routes | insufflatedoral | insufflated |
Desoxypipradrol, a Stimulants, and 2-FMA, a Stimulants, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Stimulantss, meaning they share a common pharmacological foundation. They share 23 documented effects in common, with 8 effects unique to Desoxypipradrol and 14 unique to 2-FMA. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Desoxypipradrol | 2-FMA | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (insufflated) | 1.5–3.5 mg | 15–30 mg |
| Total Duration | 8.3–40 hrs | 1.5–4 hrs |
| Routes | insufflatedoral | insufflated |
| Effects | 31 documented | 37 documented |
| Level | Desoxypipradrol | 2-FMA |
|---|---|---|
| Threshold | 0.25 mg | 5 mg |
| Light | 0.5–1.5 mg | 5–15 mg |
| Common | 1.5–3.5 mg | 15–30 mg |
| Strong | 3.5–5 mg | 30–50 mg |
| Heavy | 5 mg | 50 mg |
| Level | Desoxypipradrol | 2-FMA |
|---|---|---|
| Threshold | 0.25 mg | 5 mg |
| Light | 1–2 mg | 5–15 mg |
| Common | 2–6 mg | 15–30 mg |
| Strong | 6–8 mg | 30–50 mg |
| Heavy | 8 mg | 50 mg |
Desoxypipradrol
Total: 10 hrs – 72 hrs
2-FMA
Total: 4 hrs – 6 hrs
Desoxypipradrol
Total: 16 hrs – 72 hrs
2-FMA
No direct interaction data available between these substances. This does not mean the combination is safe.
Total: 7 hrs – 9 hrs